ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

127 hedge funds and large institutions have $469M invested in Intra-Cellular Therapies Inc. in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 28 reducing their positions, and 13 closing their positions.

Holders
127
Holders Change
–
Holders Change %
0%
% of All Funds
2.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
52
Reduced
28
Closed
13
Calls
$42.6M
Puts
$4.38M
Net Calls
+$38.2M
Net Calls Change
+$666K

Top Buyers

1
TA
1
Teachers Advisors
New York
$5.74M
2
WA
2
Wasatch Advisors
Utah
$28.8M
3
RPAM
3
Rhenman & Partners Asset Management
Sweden
$11.6M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$51.4M
5
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$16.5M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$1.13M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
FCM
3
Farallon Capital Management
California
$0
4
Millennium Management
4
Millennium Management
New York
$8.68M
5
Bank of America
5
Bank of America
North Carolina
$1.46M
Name Market Value Shares Shares
Change 		Shares
Change %
GTC
151
Ghost Tree Capital
New York
– – – –
Simplex Trading
152
Simplex Trading
Illinois
– – – –
PCP
153
Proficio Capital Partners
Massachusetts
$0 29 +29 New
3 4 5 6
7